Bivalent vaccine against Fasciolosis and Schistosomiasis

Project 118

Problem to be solved

• Endemic diseases of worldwide range with high morbidity and mortality
• Absence of vaccine to control the diseases
• Great losses in cattle

Proposed innovation

• Vaccine formulation to prevent fasciolosis and schistosomiasis
• Controls hepatic fasciolosis in cattle, goat and sheep

Differential

• Antigen validated by OMS
• Effective and lasting protection
• Vaccine for human and veterinary use

Development status
Pre-clinical

Intellectual property status
BRPI9305075-5, BRPI0308978-9, BRPI0303266-3 (corresponding application filed in Europe, United States, Australia, Japan, New Zealand, South Africa, Canada, Cuba, Egypt, India, ARIPO and OAPI)

What we want
Partnership

Coordinator
Miriam Tendler / IOC

Contact
Gestec/VPPIS – phone: 21 3882 9099/ 3882 9120 or portfolio@fiocruz.br